Tarsus Pharmaceuticals, Inc. (TARS)
Irvine, CA
Total Compensation for Fiscal Year Ending in 2024: $7,896,192
| Salary | $673,400 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $3,370,153 |
| Value of Option Awards | $3,267,692 |
| Non-Equity Incentive Plan Compensation | $532,800 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $52,147 |
| Total | $7,896,192 |
Tarsus Pharmaceuticals, Inc. disclosed its CEO pay was
37
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?
